1. Home
  2. AU vs RGEN Comparison

AU vs RGEN Comparison

Compare AU & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AU
  • RGEN
  • Stock Information
  • Founded
  • AU 1944
  • RGEN 1981
  • Country
  • AU United States
  • RGEN United States
  • Employees
  • AU N/A
  • RGEN N/A
  • Industry
  • AU Precious Metals
  • RGEN Medical/Dental Instruments
  • Sector
  • AU Basic Materials
  • RGEN Health Care
  • Exchange
  • AU Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • AU 10.3B
  • RGEN 7.6B
  • IPO Year
  • AU 1972
  • RGEN N/A
  • Fundamental
  • Price
  • AU $26.38
  • RGEN $156.55
  • Analyst Decision
  • AU Hold
  • RGEN Buy
  • Analyst Count
  • AU 5
  • RGEN 12
  • Target Price
  • AU $31.75
  • RGEN $187.44
  • AVG Volume (30 Days)
  • AU 2.5M
  • RGEN 470.1K
  • Earning Date
  • AU 11-07-2024
  • RGEN 02-19-2025
  • Dividend Yield
  • AU 0.84%
  • RGEN N/A
  • EPS Growth
  • AU N/A
  • RGEN N/A
  • EPS
  • AU 1.34
  • RGEN N/A
  • Revenue
  • AU $5,299,000,000.00
  • RGEN $633,513,000.00
  • Revenue This Year
  • AU $31.38
  • RGEN $2.28
  • Revenue Next Year
  • AU $28.36
  • RGEN $9.88
  • P/E Ratio
  • AU $18.96
  • RGEN N/A
  • Revenue Growth
  • AU 17.78
  • RGEN N/A
  • 52 Week Low
  • AU $15.80
  • RGEN $113.50
  • 52 Week High
  • AU $32.57
  • RGEN $211.13
  • Technical
  • Relative Strength Index (RSI)
  • AU 60.56
  • RGEN 60.07
  • Support Level
  • AU $25.26
  • RGEN $149.15
  • Resistance Level
  • AU $26.24
  • RGEN $160.64
  • Average True Range (ATR)
  • AU 0.54
  • RGEN 5.96
  • MACD
  • AU 0.37
  • RGEN 0.91
  • Stochastic Oscillator
  • AU 94.24
  • RGEN 79.57

About AU AngloGold Ashanti PLC

Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: